Jefferies Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.37M | Sell |
57,628
-28,991
| -33% | -$2.92M | 0.05% | 297 |
|
|
2022
Q2 | $6.49M | Buy |
86,619
+5,667
| +7% | +$417K | 0.05% | 291 |
|
|
2022
Q1 | $6.32M | Buy |
80,952
+68,541
| +552% | +$5.25M | 0.04% | 352 |
|
|
2021
Q4 | $1.12M | Buy |
+12,411
| New | +$1.06M | 0.01% | 967 |
|
|
2021
Q3 | – | Sell |
-509
| Closed | -$39.6K | – | 1999 |
|
|
2021
Q2 | $39.6K | Buy |
509
+276
| +118% | +$20.9K | ﹤0.01% | 1557 |
|
|
2021
Q1 | $17.4K | Sell |
233
-9,859
| -98% | -$910K | ﹤0.01% | 1551 |
|
|
2020
Q4 | $1.72M | Buy |
10,092
+683
| +7% | +$101K | 0.01% | 761 |
|
|
2020
Q3 | $1.32M | Sell |
9,409
-163
| -2% | -$24.8K | 0.01% | 716 |
|
|
2020
Q2 | $1.53K | Sell |
9,572
-2,338
| -20% | -$318K | 0.02% | 652 |
|
|
2020
Q1 | $1.17M | Sell |
11,910
-20,812
| -64% | -$2.38M | 0.01% | 942 |
|
|
2019
Q4 | $4.22M | Sell |
32,722
-11,332
| -26% | -$1.14M | 0.03% | 606 |
|
|
2019
Q3 | $3.32M | Buy |
44,054
+18,437
| +72% | +$2.18M | 0.03% | 746 |
|
|
2019
Q2 | $3.89M | Buy |
25,617
+10,772
| +73% | +$1.31M | 0.03% | 591 |
|
|
2019
Q1 | $1.77M | Buy |
14,845
+1,148
| +8% | +$148K | 0.01% | 976 |
|
|
2018
Q4 | $1.5M | Buy |
13,697
+1,838
| +15% | +$230K | 0.01% | 972 |
|
|
2018
Q3 | $1.92M | Sell |
11,859
-17,191
| -59% | -$2.35M | 0.01% | 1004 |
|
|
2018
Q2 | $3.84M | Buy |
+29,050
| New | +$2.74M | 0.02% | 607 |
|
|
2018
Q1 | – | Sell |
-40,000
| Closed | -$2.23M | – | 2683 |
|
|
2017
Q4 | $2.23M | Buy |
+40,000
| New | +$2.12M | 0.01% | 940 |
|
|
2017
Q1 | – | Sell |
-839,342
| Closed | -$26M | – | 2635 |
|
|
2016
Q4 | $23M | Sell |
839,342
-1,476,872
| -64% | -$59.3M | 0.13% | 134 |
|
|
2016
Q3 | $142M | Buy |
2,316,214
+1,630,585
| +238% | +$49.3M | 0.73% | 17 |
|
|
2016
Q2 | $13.1M | Sell |
685,629
-472,150
| -41% | -$8.75M | 0.06% | 221 |
|
|
2016
Q1 | $22.6M | Buy |
+1,157,779
| New | +$20.2M | 0.13% | 104 |
|
|
2015
Q4 | – | Sell |
-5,943
| Closed | -$193K | – | 2551 |
|
|
2015
Q3 | $191K | Buy |
+5,943
| New | +$202K | ﹤0.01% | 1942 |
|
|
2015
Q2 | – | Sell |
-42,203
| Closed | -$863K | – | 3483 |
|
|
2015
Q1 | $560K | Buy |
42,203
+20,774
| +97% | +$277K | ﹤0.01% | 1332 |
|
|
2014
Q4 | $310K | Sell |
21,429
-162,377
| -88% | -$2.75M | ﹤0.01% | 1530 |
|
|
2014
Q3 | $3.88M | Sell |
183,806
-173,604
| -49% | -$3.92M | 0.03% | 506 |
|
|
2014
Q2 | $10.6M | Sell |
357,410
-270,389
| -43% | -$8.55M | 0.09% | 195 |
|
|
2014
Q1 | $15.1M | Sell |
627,799
-41,663
| -6% | -$1.06M | 0.15% | 129 |
|
|
2013
Q4 | $13.6M | Buy |
669,462
+95,391
| +17% | +$2.83M | 0.09% | 122 |
|
|
2013
Q3 | $27.1M | Buy |
574,071
+144,332
| +34% | +$5.56M | 0.26% | 52 |
|
|
2013
Q2 | $16.3M | Buy |
+429,739
| New | +$15.4M | 0.18% | 89 |
|
Other funds holding SRPT
ACA
EC
Jefferies Group's SRPT Position: Q3 2022 in Review
Jefferies Group reduced its Sarepta Therapeutics (SRPT) stake by 33% in Q3 2022, selling an estimated $2.92M and leaving 57,628 shares worth $6.37M. The position accounts for 0.05% of the portfolio, ranked #297.
Jefferies Group first reported a position in SRPT in Q2 2013 and has held it in 31 quarters since. The position peaked at $142M in Q3 2016. 375 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.
- Jefferies Group held 57,628 shares of Sarepta Therapeutics worth $6.37M as of Q3 2022.
- Jefferies Group sold 28,991 Sarepta Therapeutics shares in Q3 2022, an estimated $2.92M.
- Sarepta Therapeutics made up 0.05% of Jefferies Group's portfolio in Q3 2022, its #297 holding.
- Jefferies Group first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 31 quarters since.
- Jefferies Group's Sarepta Therapeutics position peaked at $142M in Q3 2016.
- 375 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.